Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Page No.:
1 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
1.
OBJECTIVE :
1.1.
To lay down a procedure for managing and reporting of deviation, unexpected events and
incidents, and their investigation at Alkem Labs. Ltd. manufacturing plant in Amaliya, Daman.
1.2.
This Standard Operating Procedure defines key system requirements to ensure that there is a
consistent approach to investigations of unplanned deviations. Compliance with this SOP will
also ensure that each investigation is conducted properly and in a timely manner, that corrective
and preventive actions are implemented, and that tracking, follow-up and trending mechanisms
are employed to ensure compliance with GMPs.
2.
SCOPE :
2.1.
Any deviation from approved procedures must be clearly described and justified. This
procedure applies to unplanned deviations, other than:
2.1.1.
Laboratory chemistry and microbiology Out Of Specifications OOS, and other similar
laboratory unexpected results, such as Out Of Limit OOL, and Out of Trend OOT.
Laboratory Investigations may be handled under the Laboratory Investigations System.
They are covered in SOP for Out Of Specification (SOP No. AC/QC/010) and Handling
of Laboratory incidences (SOP No. AC/QC/093).
2.1.2.
Planned deviations. They are covered in SOP for Change Control Procedure (SOP No.
AC/QA/010) and are referred in that SOP as Temporary Change Control.
2.2.
This procedure is applicable to all unplanned deviations in all departments in Alkem Daman.
For example, but not limited to the Production, Quality Control, Quality Assurance, Engineering,
Personnel & Administration, Warehouse at Alkem Laboratories Limited, Amaliya, Daman.
ALKEM
Laboratories Limited, Daman
Page No.:
2 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
2.3. Policy:
2.3.1. This SOP assures that deviations relating to the manufacturing and distribution of production
materials are thoroughly investigated and documented. These procedures include addressing
deviations that may occur in the production of development and validation batches.
2.3.2. These procedures address the following elements:
2.3.2.1. Identification of reportable events
2.3.2.2. Prompt communication of event and investigation to appropriate parties
2.3.2.3. Identification and responsibilities of the investigators
2.3.2.4. Root cause analysis
2.3.2.5. Evaluation of the impact on other processes, other batches and other facilities
2.3.2.6. Evaluation of quality and final disposition of the production materials
2.3.2.7. Steps of initial and subsequent investigations
2.3.2.8. Proper and timely documentation of investigation to include:
2.3.2.8.1.
2.3.2.8.2.
2.3.2.8.3.
2.3.2.8.4.
2.3.2.8.5.
2.3.2.8.6.
2.3.2.8.5.1.
2.3.2.8.5.2.
2.3.2.8.5.3.
2.3.2.8.5.4.
ALKEM
Laboratories Limited, Daman
Page No.:
3 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
2.3.2.8.7.
2.3.2.8.8.
2.3.2.8.9.
3.0
The following outlines the key roles and associated responsibilities within the investigation
process:
3.1.1
All Personnel
3.1.1.1 Identify and communicate Reportable Event(s).
3.1.1.2 Take Immediate Action(s).
3.2
3.3
3.2.2
3.2.3
Assign disposition.
Investigator/investigation Team
3.3.1
3.3.2
ALKEM
Laboratories Limited, Daman
Page No.:
4 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
3.4
3.5
3.6
Site Management
3.4.1
Assign adequate and qualified resources for investigations and commitment tracking.
3.4.2
3.4.3
3.5.2
4.0
ACCOUNTABILITY :
4.1
Head Quality assurance is accountable for Approval of Deviation, Implementation & Periodic
review of system.
5.0
PROCEDURE:
5.1
Definition:
Deviation includes but is not limited to any departure, difference, divergence, variation,
fluctuation, change, irregularity, abnormality, variance, or discrepancy from approved written
procedure - a nonconformity of SOP, systems and specifications. An incident may not be a
deviation. A deviation is a reportable event
An unplanned deviation is a deviation detected during the process
Minor Deviation (Non-Critical) a deviation unlikely to have a detectable impact on quality or
system capability
Major Deviation (Critical) a deviation that could have a significant impact on the quality or
system capability
ALKEM
Laboratories Limited, Daman
Page No.:
5 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
OOF : Out of Frequency, the recalibration or revalidation are conducted exceed the planned
schedule.
OOA : Out of Alert level , the monitoring data exceed the trending
OOS : Out of Specification, the testing result are exceed the limit in specification
OOT : Out of Tolerance, the measurement result of equipment exceeds the accepted limit.
OOV : Out of Verification, using material before release
OEM : Out of Environment Monitoring
Root Cause is the most basic cause of a deviation and / or failure in a process, component
or product. An identified reason for the presence of a defect or problem, which if eliminated,
would prevent recurrence. A root cause of a consequence is any basic underlying cause that
was not in turn caused by more important underlying causes
5.2
A deviation investigation may be initiated upon review of information obtained from but not
limited to
5.2.1
annual reviews,
5.2.2
quality audit reports (including internal audits, third party customer audits and or
regulatory audits),
5.2.3
Quality Control results other than those handled by the OOS procedures, AC/QC/010,
5.2.4
Equipment-use logs,
5.2.5
5.2.6
5.2.7
5.2.8
Yield
5.2.9
ALKEM
Laboratories Limited, Daman
Page No.:
6 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
Examples
Wrong version, unapproved document, data
5.3.1
Use of Documents
5.3.2
5.3.3
Procedures
Batch/Packaging
o
o
Incoming
Record
5.3.4
Materials
Requiring
QA
including
Release
5.3.5
Sampling
5.3.6
Incoming Materials
Materials
5.3.7
Their Status
Process
damaged
or
incorrect
shipment,
missing
or
of
and
or incorrect documentation.
Incorrect or
unapproved
material
used,
questionable release.
Control
Parameters
5.3.8
Sampling
5.3.9
Material
Holding
and
Holding
Time
missing or incorrect.
Procedure not followed, not applicable.
o
vessel used.
5.3.10
Conditions
Environmental
5.3.11
Controls
Calibration
Parameters
exceed
action
limits,
leak,
unauthorized entry.
Equipment out of calibration or tolerance, log
ALKEM
Laboratories Limited, Daman
Page No.:
7 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
CATEGORY
5.3.12
Examples
or sticker missing.
Equipment
used.
5.3.13
5.3.14
5.3.15
Facility Issues
Yields
Quality
5.3.16
Data Entries
5.3.17
Signatures/Approv
o
o
o
explanations inappropriate.
Inconsistent dates / initials, lack of, or
als
5.3.18
5.3.19
Function/
inappropriate approvals.
Equipment or Area
Cleaning
Sterilization,
Sanitation
and
Line
Clearances
Validation related
Testing
5.3.21
Product
clearance
failure,
not
satisfactorily
Events
5.3.20
Line
to
meet
validation/revalidation
Identification Discrepancy
Mixed
Lots
on
ALKEM
Laboratories Limited, Daman
Page No.:
8 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
CATEGORY
Pallet
5.3.23
SOP Procedure
Examples
proper placard and separation.
Failure to execute - A SOP or job aid exists
but is not being followed.
5.3.24
Third Party
5.3.25
Vendor or
5.3.26
Supplier Issues
No SOP available.
o
o
5.3.27
5.3.28
Mechanical
Potential Product
Failure
5.3.29
Defect
ALKEM
Laboratories Limited, Daman
Page No.:
9 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
ALKEM
Laboratories Limited, Daman
Page No.:
10 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.6 Timing:
5.6.1
The Quality Assurance shall be notified and a unique tracking number shall be
assigned within one business day (the normal operating days for a facility at Daman or
functional unit (such as G-Block), typically Monday through Saturday) of the date that
the reportable event was detected:
5.6.2
The investigation report shall be completed and approved within 30 calendar days of
the initiation date, unless the Quality Assurance Unit approves an extension. The
initiation date is the date the unique tracking number is assigned. All extension
requests shall be justified and documented.
5.7 Amendments:
5.7.1
5.7.2
The reason for the amendment and any additional supporting documentation shall be
included in the amended investigation.
5.7.3
ALKEM
Laboratories Limited, Daman
Page No.:
11 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.10System Linkages: Other SOPS or systems that may be relevant but are not limited to:
Subject
a) Change Control
b) Batch Record Release
Full title
Change Control Procedure
Batch record auditing for approval or rejection
SOP Number
AC/QA/010
AC/QA/036
c) Preventive Maintenance
d) Annual Product Review
e) Stability
f) Training
g) Materials Management
of batch.
Planned Preventive Maintenance,
Product Quality Review
Stability Studies
Plant personnel Training
Receipt, Identification, Storage and movement
A/EM/001
A/QA/009
AC/QC/001
AC/QA/003
A/WH/102
(PM) in warehouse.
Reporting of Laboratory incident / Discrepancy
Handling of Corrective and preventive and
AC/QC/093
AC/QA/005
preventive action
j) Failure investigation
Failure investigation
AC/QA/006
k) Market Complaint
Handling of Market Complaint
AC/QA/008
5.11
All personnel who observes any deviation anywhere at any time must immediately report the
event in writing to the area supervisor / in-charge and Quality assurance.
5.12
ALKEM
Laboratories Limited, Daman
Page No.:
12 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.12.5 Event shall be reported in pre-numbered format (Refer Annexure VII) having 6 digit as
XYNNNN where,
5.12.5.1
Y represents Last digit for the year (i.e. 8 for 2008) and NNNN
represents a serial number starting from 0001.
Originating Department
5.12.6.2
Slip Number
5.12.6.3
Date of detection
5.12.6.4
5.12.6.5
5.12.6.6
5.12.6.7
Stage of Manufacturing
5.12.6.8
Facility
5.12.6.8.2
System
5.12.6.8.3
Equipment
5.12.6.8.4
Components
ALKEM
Laboratories Limited, Daman
Page No.:
13 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.12.6.8.5
Product
5.12.6.8.6
others
5.12.6.9
5.12.6.10
5.12.6.11
5.12.6.12
5.12.7 A database in the form of a register (Refer Annexure VIII) shall be maintained for
tracking the status of each reported event including. The register will comprise the
following information, but not limited to:
5.13
5.12.7.1
Date of event
5.12.7.2
5.12.7.3
Origination Department
5.12.7.4
Identity of product
5.12.7.4.1
Facility
5.12.7.4.2
System
5.12.7.4.3
Equipment
5.12.7.4.4
Components
5.12.7.4.5
Product
5.12.7.4.6
others
5.12.7.5
5.12.7.6
Remarks.
Immediate Action(s):
5.13.1 The following actions shall occur within one business day, but not necessarily in the
listed order.
5.13.1.1
ALKEM
Laboratories Limited, Daman
Page No.:
14 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.13.1.2
5.13.1.3
Supervisor and Block Quality Assurance will evaluate the event and take
decision on category of event i.e.
5.13.1.3.1
Reportable only, or
5.13.1.3.2
Deviation.
5.13.1.4
5.13.1.5
5.13.1.5.1
5.13.1.5.2
ALKEM
Laboratories Limited, Daman
Page No.:
15 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.13.1.5.4
The forth and fifth character YY shall represent the year like 08
for year 2008.
5.13.1.5.5
5.13.1.5.6
5.13.1.5.7
production materials
5.13.4.2
Equipment
5.13.4.3
Areas
5.13.4.4
Processes
5.13.4.5
procedures,
5.13.4.6
5.13.4.7
Materials
5.13.4.7.2
equipment
5.13.4.7.3
Areas
5.13.4.7.4
Processes
5.13.4.7.5
Procedures
ALKEM
Laboratories Limited, Daman
Page No.:
16 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.13.4.8
5.13.5 Assess the potential need for a Market Alert or other Regulatory Notification and if
required, contact Senior Management in Alkem HQ.
5.13.6 Link the reportable event involving production materials to Batch Record Review and
Release System.
5.14
Classification of Deviation: The Quality Assurance shall have the final authority to determine
if an investigation is necessary for each deviation.
5.14.1 Reportable Only - These events have minimal or no impact on production materials /
equipment / areas / processes / procedures and are limited in nature. The event and
circumstances surrounding that event shall be considered when determining if an
investigation is required. The rationale for not investigating a reportable event shall be
documented. Reportable only events may include:
5.14.1.1 Minor Batch Record or documentation errors not affecting the integrity of
data.
5.14.1.2 Repeat event(s) for which the root cause is known and for which corrective /
preventative actions have been identified, but implementation has not been
completed. The repeat event must be linked to the original investigation.
5.14.1.3 Events for which the root cause is known and for which the actions required
to address these events are governed by appropriate facility / functional unit
procedures.
ALKEM
Laboratories Limited, Daman
Page No.:
17 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.14.1.4 If trending indicates that the frequency of the reportable event is repetitive
(as defined by facility / functional unit procedures), the need for performing
an investigation shall be evaluated.
5.14.2 Deviations that Require Investigation
5.14.2.1 All deviations that are not classified as reportable only" shall be investigated.
5.14.2.2 An investigation shall be conducted when the frequency of similar "reportable
only" events is determined to be unacceptable (e.g.. exceeds pre-established
limits). The scope of the event must be assessed to determine whether the
event is isolated or if a pattern exists (refer annexure V). Data for a sufficient
period of time or number of batches / lots must be reviewed to identify any
similar or identical events that may be indicative of a trend or a common root
cause. The number of batches / lots and / or the time period will vary
depending on the reported event.
5.14.2.3 If after the initiation of the investigation, it is determined that no investigation
was warranted, the investigation may be closed in the tracking system.
Closure of the investigation shall require documented rationale that is
approved by the responsible functional area management and the Quality
Assurance.
5.14.3 The Investigation - The Quality Assurance shall approve the documented rationale for
continued use of production materials / equipment / areas / processes / procedures
impacted by the investigation.
5.14.4 The functional unit management shall assign resources needed to perform the
investigation, including an investigator/ investigation team. Unless otherwise directed
personnel from the department along with IPQA person shall jointly investigate the root
cause of deviation.
5.14.5 A due date for completion for each investigation shall be established.
ALKEM
Laboratories Limited, Daman
Page No.:
18 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.14.6 The investigation report shall be completed and approved within 30 calendar days of
the initiation date, unless the Quality Assurance approves an extension. The initiation
date is the date the unique tracking number is assigned. All extension requests shall be
justified and documented.
5.14.7 The functional unit shall define how investigations are addressed that exceeds the due
date.
5.14.8 The investigation report shall
5.14.8.1 Assess the likely implication of deviation on existing process / activity /
product / parameters etc.
5.14.8.2 Define the steps taken to resolve the deviation (correction) and suggested
corrective action for the current stage
5.14.8.3 QA shall review the investigation and then shall forward the deviation form to
other concern department, if required.
5.14.8.4 After getting comments from other concern department the deviation form
shall be forwarded to Head Operations for review and comments.
5.14.8.5 The deviation form shall then be forwarded to Head Quality Assurance who
shall evaluate the deviation and decides the approval / Rejection.
5.14.8.6 All deviations need correction, corrective action and or preventative action
depending on the category. The QA head shall approve the degree of the
CAPA system based on category of deviation. All deviations deemed to be
critical for quality of product, system or may pose a compliance risk, shall use
CAPA as outlined in the SOP no. AC / QA / 005.
5.14.8.7 The QA-in-charge shall ensure implementation of the corrective actions after
evaluation and approval of the deviation form by Head Quality Assurance.
5.14.8.8 On completion of the corrective activity the deviation shall be closed by the
QA.
ALKEM
Laboratories Limited, Daman
Page No.:
19 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
ALKEM
Laboratories Limited, Daman
Page No.:
20 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
ALKEM
Laboratories Limited, Daman
Page No.:
21 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
ALKEM
Laboratories Limited, Daman
Page No.:
22 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.19
Investigation Report
5.19.1 The results of the investigation shall be documented in a clear, comprehensive report
that shall include, but is not limited to:
ALKEM
Laboratories Limited, Daman
Page No.:
23 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.19.1.1
5.19.1.2
5.19.1.3
5.19.1.4
5.19.1.5
Data collection
5.19.1.6
Data Analysis
5.19.1.7
5.19.1.8
5.19.1.9
ALKEM
Laboratories Limited, Daman
Page No.:
24 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.20.3 Reviewers and approvers shall ensure that the investigation is clear, identifies the
scope, depth, root cause and appropriate corrective/preventive actions. Points to
consider may include:
5.20.3.1 Documentation package complete including attachments/ references as
applicable.
5.20.3.2 Compliance to GMP.
5.20.3.3 Appropriate regulatory input obtained.
5.20.3.4 Applicable root causes properly investigated.
5.20.3.5 Most probable root cause chosen based on supporting data and sound
scientific reasoning.
5.20.3.6 Appropriateness,
adequacy
and
timeliness
of
actions
taken-and
recommended.
5.20.3.7 Appropriate personnel included in the review and a process.
5.20.4 Reviewers and approvers shall ensure that the information presented in the
investigation is clear and has the appropriate scope and depth.
5.20.5 Reviewers and approvers shall document agreement with the facts as presented.
5.21
5.22
ALKEM
Laboratories Limited, Daman
Page No.:
25 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.22.1.3 all commitments are entered into the commitment tracking system.
5.22.1.4 Corrective / preventive actions that were required to be completed prior to
the investigation closure have been completed.
5.22.2 Final Disposition
5.22.2.1 Final disposition decision related to production materials / equipment /
areas/processes/procedures shall be documented and justified by Quality
Assurance.
5.22.2.2 Disposition actions (e.g. reject. release, return to service) shall be taken
when relevant investigations are completed and closed.
5.23
Commitment Tracking
5.23.1 A system is required for entering and tracking commitments. This system shall track, at
a minimum, the commitment, the responsible individuals, the investigation number, due
date, and completion date.
5.23.2 The Quality Assurance shall approve changes to commitments.
5.23.3 The functional unit procedures shall define the approval process for changing due
dates and/or responsible persons and for verifying the completion of commitments.
5.23.4 The facility/functional unit shall determine the content, frequency of issuance and
distribution of periodic status reports of open and overdue commitments.
ALKEM
Laboratories Limited, Daman
Page No.:
26 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.24
Metrics
5.24.1 There shall be a system for tracking and reporting metrics, including, but not limited to,
the status of all open and any overdue investigations and commitments.
5.24.2 The frequency of reporting metrics shall be on a regular predetermined basis (at least
annual)
5.24.3 The Alkem Daman top management as the GMP Committee shall review metric reports
to:
5.24.3.1 identify
any
actions
needed
to
improve
timeliness
of
completing
investigations.
5.24.3.2 determine the effectiveness of corrective and preventive actions.
5.24.3.3 measure the performance of the investigation process.
5.25
Trending
5.25.1 A trend is a pattern that indicates a change in the expected frequency or occurrence.
5.25.2 There shall be trend analysis of deviations and investigation data including:
5.25.2.1 Event category
5.25.2.2 Root Cause category
5.25.2.3 Functional Area category (e.g., C-Block, B-Block, Quality Assurance, etc.)
5.25.3 Quality Assurance shall carry out trend analysis for all the deviations in the whole year
at the beginning of the next year as per the Trend Analysis of Deviation format as per
Annexure V.
5.25.4 A copy of the trend analysis shall be forwarded to Regulatory compliance, Head
Quality Assurance, and Head Operations.
ALKEM
Laboratories Limited, Daman
Page No.:
27 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
5.26
Record Retention:
5.26.1 Investigation reports shall be included or referenced in all related batch records or
applicable reports.
5.26.2 The record retention for all closed investigation reports shall be not less than 7 years,
or as otherwise agreed wit the regulatory body concerned.
5.26.3 Investigation reports shall be stored in a secure and easily retrievable manner.
5.26.4 Maintain all Deviation records in a separate register for tracking as per Annexure III.
6.0 TRAINING:
6.1 Training: All personnel involved in the investigation process (from identifying an event through
record retention) shall be properly trained to perform assigned tasks.
7.0 DISTRIBUTION:
Certified Copy No. 1
: Head Operations
: In charge PM QC
ALKEM
Laboratories Limited, Daman
Page No.:
28 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
Supersedes:
AC/QA/004-00
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
: In charge IT Department
: Head RA Department.
: Head CQA.
: Head FnD.
: Head ADL.
Original Copy
8.0 ANNEXURE :
9.0
Annexure I
Deviation Record.
Annexure II
Annexure III
Flow chart
Annexure IV
Annexure V
Annexure VI
Annexure VII
Annexure VIII
REFERENCE:
Nil
ALKEM
Laboratories Limited, Daman
Page No.:
29 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
Effective Date
Revision details
1.Change in Annexure
2.Formatting as per SOP for
04
22.12.2006
SOP
17.05.2007
00
04.09.2007
Inclusion
of
Definition
of
Deviation.
SOP
number
changed
A/QA/007 to AC/QA/004.
Annexure
III
Note
from
of
autorisation deleted
Time limit for closure of deviation
added.
Point number 5.5 added
Annexure I modified
analysis
assessment added.
and
impact
ALKEM
Laboratories Limited, Daman
Page No.:
30 of 30
AREA
SOP No.:
AC/QA/004
Revision No.:
01
: QUALITY ASSURANCE
AC/QA/004-00
Supersedes:
dt. 04.09.07
Effective Date:
Revision Due:
PREPARED BY
CHECKED BY
APPROVED BY
AUTHORIZED BY
Officer QA
Head of Department
Head Operations
Head QA
SIGNATURE
NAME
DATE
DESIGNATION
Revision
Number
01
Effective Date
Revision details
Redrafted in totality
better
understanding
and
such
as
Market